Dr. Koutrelakos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10710 Charter Dr
Ste G020
Columbia, MD 21044Phone+1 410-964-2212Fax+1 410-964-0380
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 1987 - 1989- Brown UniversityResidency, Internal Medicine, 1987 - 1989
Berkshire Medical CenterResidency, Internal Medicine, 1986 - 1987- Berkshire Medical CenterInternship, Internal Medicine, 1984 - 1985
University of Maryland School of MedicineClass of 1984
Certifications & Licensure
MD State Medical License 1989 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsIxabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.Cynthia Osborne, Jagathi D. Challagalla, Charles F. Eisenbeis, Frankie A. Holmes, Marcus A. Neubauer
Clinical Breast Cancer. 2017-07-10 - 24 citationsDurable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.Norma Alonzo Palma, Siraj M. Ali, Jamie O'Connor, Deepa Dutta, Kai Wang
Case Reports in Oncology. 2014-07-23 - 7 citationsPhase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patientsJohn W. Smith, Svetislava Vukelja, Amy Rabe, Nicole Wentworth-Hartung, Nicholas Koutrelakos
Breast Cancer Research and Treatment. 2013-10-29
Press Mentions
Novelties: In Cancer Treatment, New DNA ToolsApril 27th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
